Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

51.06
Delayed Data
As of Jul 29
 +0.12 / +0.24%
Today’s Change
39.28
Today|||52-Week Range
51.74
+13.42%
Year-to-Date

Today’s Trading

Previous close50.94
Today’s open50.98
Day’s range-- - --
Volume3,530,671
Average volume (3 months)4,963,649
Market cap$75.8B
Dividend yield1.88%
Data as of 07/29/2015

Growth & Valuation

Earnings growth (last year)-8.61%
Earnings growth (this year)-5.01%
Earnings growth (next 5 years)+9.95%
Revenue growth (last year)-7.33%
P/E ratio38.3
Price/Sales3.40
Price/Book3.57

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.20+0.61%
VRXValeant Pharmaceutic...-2.72-1.05%
LLYEli Lilly and Co-0.59-0.69%
SHPGShire+0.13+0.05%
Data as of 07/29/2015

Financials

Next reporting dateOctober 21, 2015
EPS forecast (this quarter)$0.54
Annual revenue (last year)$20.2B
Annual profit (last year)$2.3B
Net profit margin8.50%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
VP-Investor Relations
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts